Select Page

TAGRISSO™ (osimertinib) tablet, for oral use. Initial U.S. Approval: 2015

TAGRISSO™ (osimertinib) tablet, for oral use. Initial U.S. Approval: 2015

TAGRISSO™ (osimertinib) tablet is a prescription medicine. TAGRISSO™ (osimertinib) tablet is used for lung cancer (non-small cell lung cancer-NSCLC) treatment.

INDICATIONS AND USAGE
TAGRISSO is a kinase inhibitor indicated for the treatment of patients with metastatic epidermal growth factor receptor (EGFR) T790M mutationpositive non-small cell lung cancer (NSCLC), as detected by an FDAapproved test, who have progressed on or after EGFR TKI therapy. This indication is approved under accelerated approval based on tumor response rate and duration of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials.
DOSAGE FORMS & STRENGTHS
Tablets: 80 mg and 40 mg
Manufactured By: AstraZeneca
Prescribing Information URL: Click Here

Procedure to buy TAGRISSO™ (osimertinib) tablet?
To buy TAGRISSO™ (osimertinib) tablet, patients can simply fill the order form or can send mail at info@bioniquehealthcare.com. or can also send Whatsapp message at +91 96677 50889. You will get reply within few hours with pricing and procedure details. Note:- the order will be confirmed only after the receipt of valid prescription of doctor.

Category:

Osimertinib, sold under the brand name Tagrisso, is a medication used to treat non-small-cell lung carcinomas with specific mutations. It is a third-generation epidermal growth factor receptor tyrosine kinase inhibitor.
Osimertinib was approved for medical use in the United States in November 2015, and in the European Union in February 2016.

Documentation

  1. Doctor’s Prescription – We would require prescription from registered medical practitioner stating product name, dosage, duration of treatment and diagnosis.
  2. Patient’s Medical history – We would require all test reports and medical reports of the patient for last 3 months.
  3. Patient’s Identity card – We will require scan copy of patient’s identity card and proof of residence to initiate documentation process. you can use copy of passport, driving license, employee ID card or any photo id document as your identity card.

For Overseas Patient

Can I get anti-cancer medicines even if I am not based in India?

Almost all countries across the world have provisions for granting access to drugs prior to marketing approval for personal use for patients who have exhausted all other treatment options available in their country. The Bionique Healthcare can help patients in accessing/importing Ant-cancer medicines, unapproved in their home country against a legitimate prescription and in conformity with all local laws and regulations of their home country.

Send your query to find the best price of –

TAGRISSO™ (osimertinib) tablet in South East Asia – China (Beijing, Chongqing, Shanghai, Tianjin and Shenzhen), Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong.
TAGRISSO™ (osimertinib) tablet in United Arab Emirates – Iraq, Iran, Saudi Arabia, Jordan.
TAGRISSO™ (osimertinib) tablet in North America – Mexico.
TAGRISSO™ (osimertinib) tablet in South America – Argentina, Brazil, Chile, Colombia, Peru, Venezuela.
TAGRISSO™ (osimertinib) tablet in Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia.
TAGRISSO™ (osimertinib) tablet in Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia.
TAGRISSO™ (osimertinib) tablet in African Countries – Algeria, Mauritius, Uganda, Zimbabwe.
TAGRISSO™ (osimertinib) tablet in Australia and New Zealand.

For Indian Patient

Ani-Cancer TAGRISSO™ (osimertinib) tablet are prescription drug. 

We facilitate by-

  • Helping in documentation to import the medicine for personal use.
  • Finding Genuine and reliable source in USA, Europe and Japan.
  • Ensuring 100% transparency.

TAGRISSO™ (osimertinib) tablet can be shipped to Ahmedabad, Bangalore, Chennai, Cochin, Hyderabad, Delhi, Haryana, Jaipur, Jammu and Kashmir, Himachal Pradesh, Kolkata, Lucknow, Mumbai, Pune, Punjab and other cities in India. Bionique Healthcare does not manufacture, supply, re-sell or retail any drugs or medicines. 

Reviews

There are no reviews yet.

Be the first to review “TAGRISSO™ (osimertinib) tablet, for oral use. Initial U.S. Approval: 2015”

Your email address will not be published. Required fields are marked *

Anti-Cancer Medicine Supplier.

Bionique Healthcare is a consulting pharmaceutical company which assist Patients in accessing medicines in India. Bionique Healthcare facilitates such access only against valid prescriptions in conformity with all local laws and regulations.

Patients/ Clinicians / Researchers can contact Bionique at +91 9667750889 or write to at – info@bioniquehealthcare.com.

Product Disclaimer

Bionique Healthcare does not manufacture, supply, re-sell or retail any drugs or medicines. All trademarks and other intellectual property in relation to drugs and medicines supplied to you by suppliers are owned by their respective manufacturer or licensee. 

Bionique Healthcare does not lay any claim on them.